SCHEMBL6256409

SCHEMBL6256409

COc1ccccc1OC(C)C1CO1.Cc1nc2cc(OCC3CO3)ccc2s1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 1/20 0.42
MAPT P10636 1/20 0.39
PTPN1 P18031 1/20 0.38
FGFR1 P11362 1/20 0.38
SRC P12931 1/20 0.38
ALDH1A1 P00352 2/20 0.37
GLA P06280 1/20 0.37
HCRTR1 O43613 3/20 0.37
HCRTR2 O43614 3/20 0.37
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
CYP3A4 P08684 2/20 0.36
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HIF1A Q16665 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6256411 0.84 PDE10A (0.44) PDE10AMAPTPTPN1FGFR1SRC
SCHEMBL3960133 0.82 PDE10A (0.51) PDE10AMAPTFGFR1SRCALDH1A1
SCHEMBL3960135 0.82 PDE10A (0.51) PDE10AMAPTFGFR1SRCALDH1A1
SCHEMBL5901373 0.82 PDE10A (0.51) PDE10AMAPTFGFR1SRCALDH1A1
SCHEMBL5227730 0.73 TDP1 (0.51) MAPTFGFR1SRCALDH1A1CYP3A4
SCHEMBL5901755 0.71 CA12 (0.46) ALDH1A1CYP3A4TSHR
SCHEMBL5993543 0.71 PDE10A (0.49) PDE10AMAPTALDH1A1CYP3A4TP53
SCHEMBL5901372 0.71 PDE10A (0.49) PDE10AMAPTALDH1A1CYP3A4TP53
SCHEMBL5228972 0.69 FGFR1 (0.50) MAPTPTPN1FGFR1SRCALDH1A1
SCHEMBL5901698 0.69 FGFR1 (0.50) MAPTPTPN1FGFR1SRCALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1583760-A2 SUBSTITUTED HETEROCYCLIC COMPOUNDS CV Therapeutics Inc. (US) 2005-10-12 EP disclosed
WO-2004067506-A2 SUBSTITUTED HETEROCYCLIC COMPOUNDS CV THERAPEUTICS INC. (US) 2004-08-12 WO disclosed
EP-1406898-A1 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2004-04-14 EP disclosed
WO-2003008411-A1 SUBSTITUTED PIPERAZINE COMPOUNDS AND THEIR USE AS FATTY ACID OXIDATION INHIBITORS CV THERAPEUTICS, INC. (US) 2003-01-30 WO disclosed